Finzati - Logo
EXOZ logo

eXoZymes, Inc.

EXOZ • Biotechnology
$4.12
▲ +0.12 (+3.00%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$35.68M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.37Healthy liquidity · 2.51Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:30 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$4.12
Change3.00%
Shares Out8.66M
Market Cap$35.68M
Enterprise Value$30.77M
52W Range4.35 - 18.40
Beta2.93
P/E-3.50
P/B9.76
P/FCF-5.00
EV/EBITDA-4.06
EV/FCF-4.31

Investment DNA

How strong this company looks for long-term investors

34
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
75/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Manageable debt level · 0.37Healthy liquidity · 2.51Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 11/13/2024
Industry: Biotechnology
P/B i: 9.76
Debt / Equity i: 0.37
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.37
Current Ratio: 2.51
Quick Ratio: 2.51
Status: Good

Insider Transactions

Recent executive and insider activity

Korman Tyler Paz
Transaction: 04/09/2026
SELL
Change
-750
Price
$10.53
Filing
04/10/2026
Type
SELL
Korman Tyler Paz
Transaction: 04/08/2026
SELL
Change
-750
Price
$10.04
Filing
04/10/2026
Type
SELL
Korman Tyler Paz
Transaction: 04/01/2026
BUY
Change
+5,332
Price
$8.44
Filing
04/08/2026
Type
BUY